Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

LONDON, August 14 /PRNewswire/ --

- Connect to Local, National and Worldwide Stations and Podcasts With new Home Entertainment System

LONDON, August 14 /PRNewswire/ --

- With Photo

Radiopaq, the innovative brand that brings you thousands of internet radio stations and podcasts from across the globe via Radiopaq.com, today announces hardware that will pave the way for the future of digital radio. The Radiopaq Rp5 allows you to enjoy internet radio, alongside your favourite analogue and digital stations, without having to sit at your computer. And, most importantly, the sound quality is fantastic.

NEW YORK, August 14 /PRNewswire/ --

- The Emerging Market of Dubai Dot Com Domain Names

Dubai is growing at unprecedented levels. With its enormous expansion in real estate, tourism and the retail sector, there has never been a better time to be in the business of Dubai. DubaiVirtualRealEstate.com has been monitoring the development of Dubai, UAE and simultaneously assembling a portfolio of direct type-in domain names for the regions. This rare offering to both the business owner and investor will allow for unsurpassed virtual representation by way of the internet -- providing the ability to launch their assets to a global audience.

BAAR, Switzerland, August 14 /PRNewswire/ --

- QINO Flagship Only Possibility to Participate in JAJAH's Growth

Jajah Inc. (http://www.jajah.com), a portfolio company of QINO Flagship AG (Reuters: QINO.BN) and the world's most innovative telecommunications company, has announced a groundbreaking partnership with Intel.

JAJAH has unveiled the world's first telephony application to utilise Intel's Remote Wake technology, which turns the computer into an 'always available' communications hub by waking it up from sleep mode to accept incoming phone calls. The computer has direct access to JAJAH's IP-telephony network, enabling users to easily make and receive high quality, low cost phone calls.

DENVER, August 13 /PRNewswire/ --

- One in Four Dogs Dies of Cancer

- The Number One Cause of Death in Dogs Over the Age of Two

Dogster.com, the world's most popular and comprehensive Web site devoted to the health and happiness of dogs, has joined Morris Animal Foundation (MAF) in its global effort to find a cure for canine cancer. Dogster will donate US$2 for every new subscription or subscription extension, through September 30. To subscribe go to http://www.dogster.com, scroll down on the home page to "site updates" and the help cure canine cancer link. By subscribing, dog lovers will get access to tons of insightful and inspiring dog-centric content and directly help save their dog's life.

EDMONTON, Canada, August 13 /PRNewswire/ --

- Milestone Triggers US$10 Million Payment From Eli Lilly and Company

BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Drug Safety Monitoring Board (DSMB) for the MAESTRO-01 trial has conducted the scheduled interim analysis of efficacy and safety and has recommended that the trial continue to completion. MAESTRO-01 is the pivotal phase II/III Canadian and European study of dirucotide (MBP8298) in patients with secondary progressive MS.

WELLESLEY HILLS, Massachusetts, August 13 /PRNewswire/ --

Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today that all pharmaceutical intellectual property will be sold at a sealed bid auction on October 10, 2008.

One of the pieces of intellectual property for sale is its lead product, SRx-502, a once-a-day version of a branded drug that currently has more than US$2 billion in sales despite twice daily dosing and an unfavorable AE profile. A clear clinical pathway for SRx-502 has been defined by the FDA for a 505(b)(2) regulatory submission. A successful bidder may make the NDA submission in 2Q 2009 with the remaining clinical trials expected to cost US$7 million.